Organon (OGN) and Lilly (LLY) Expand Migraine Commercialization Agreement to 11 Additional Markets
Go back to Organon (OGN) and Lilly (LLY) Expand Migraine Commercialization Agreement to 11 Additional Markets| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1123.91 -25.45 (2.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1149.36 | 52 Week High | $88.16 | |||
| Open | $1133.00 | 52 Week Low | $67.88 | |||
| Day High | $1134.53 | P/E | 260.16 | |||
| Day Low | $1113.55 | EPS | $4.32 | |||
| Volume | 2,402,850 | |||||
| (NYSE: OGN) | Delayed: 13.75 -0.03 (0.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.78 | 52 Week High | $8.00 | |||
| Open | $13.77 | 52 Week Low | $8.00 | |||
| Day High | $13.78 | P/E | N/A | |||
| Day Low | $13.75 | EPS | $0.00 | |||
| Volume | 1,629,816 | |||||

